Publications

Publications

  2017 2016  

 

2017

  1. Celeln C, Chuang J, Luo X, Nijem N, Walker AK, Chen F, Zhang S, Chung AS, Nguyen LH, Nassour I, Budhipramono A, Sun X, Bok LA, McEntagart M, Gevers EF, Birnbaum SG, Eisch AJ, Powell CM, Ge W, Santen GWE, Chahrour M, Zhu H. 2017. Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment. eLIFE. 6:e25730. doi: 10.7554/eLife.25730. 

  2. Han T, Goralski M, Gaskill N, Capota E, Kim J, Ting TC, Xie Y, Williams NS, Nijhawan D. 2017. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science. 356: eaal3755. doi: 10.1126/science.aal3755.  

Return to top


2016

  1. Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J. 2016. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature. 539(7627):112-7. doi: 10.1038/nature19796. 
  2. Kim J, Kim MS, Koh AY, Xie Y, Zhan X. 2016. FMAP: Functional Mapping and Analysis Pipeline for metagenomics and metatranscriptomics studies. BMC Bioinformatics. 17(1):420. doi: 10.1186/s12859-016-1278-0. 

  3. Chen KS, Kwon WS, Kim J, Heo SJ, Kim HS, Kim HK, Kim SH, Lee WS, Chung HC, Rha SY, Hwang TH. 2016. A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma. Cold Spring Harb Mol Case Stud 2:a000992. doi: 10.1101/mcs.a000992. 

  4. Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE. 2016. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 16:e190–95. doi: 10.1016/ S1473-3099(16)30021-4. 

Return to top